AMGEN Inc
NASDAQ: AMGN
$294.53
+$4.63 (+1.6%)
Closing Price on November 22, 2024
AMGN Articles
Amgen shares rose early Wednesday after it released better than expected second-quarter financial results late on Tuesday.
Published:
Last Updated:
The July 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
Last Updated:
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The June 28 short interest data has been compared with the previous report, and short interest in most...
Published:
Last Updated:
The June 14 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
Last Updated:
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The May 31 short interest data have been compared with the previous report, and short interest in most...
Published:
Last Updated:
Amgen is the largest of all biotechs now, and it is being deemed an "ASCO winner" for cancer and oncology news. At least, that is the view of Credit Suisse.
Published:
Last Updated:
The May 15 short interest data have been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
Last Updated:
Despite the wearing down of hepatitis C drugs and the political climate targeting drug prices, this analyst sees stabilization and predictability in the base businesses of two key biotech leaders.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday included AK Steel, Amgen, Booking, Chubb, Chipotle Mexican Grill, Expedia, Gilead Sciences, Goodyear, Philip Morris, Target and...
Published:
Last Updated:
24/7 Wall St. reviews dozens of analyst research reports each day of the week to find new ideas for investors and traders alike. Some of these analyst reports cover stocks to buy, while others cover...
Published:
Last Updated:
The April 30 short interest data have been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
Last Updated:
The April 15 short interest data have been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
Last Updated:
24/7 Wall St. has looked over some of the biotech sector's laggards, and we have also looked over the top exchange-traded funds for a breakdown of what they own to show how much they are lagging...
Published:
Last Updated:
Jefferies did a deep dive into the health care sector, looking for underperforming stocks that could hold some solid value going forward.
Published:
Last Updated:
The March 29 short interest data have been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
Last Updated: